EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Preliminary evaluation of a commercially available GnRH-based immunocontraceptive

Milena Rocha, Mauricio Favoreto, Barbara Loureiro

Clinical Theriogenology · 07.08.2026 · 18

DOI: 10.58292/ct.v18.13815 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Theriogenology, online erschienen am 07.08.2026. Verfasst von Milena Rocha und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stray dog population control is a global concern due to its implications for public health and animal welfare. Immunocastration relies on the immunological blockade of gonadotropin releasing hormone (GnRH) and represents a viable alternative to surgical sterilization. We evaluated the effects of a commercially available immunocontraceptive on ovarian activity in prepubertal female dogs; 4 were treated with antiGnRH (2 treatments, 4 weeks apart) and 3 served as controls. Dogs were monitored for signs of estrus for 7-8 months after the second treatment and progesterone concentrations were determined. Ovaries and uterus were collected after ovariohysterectomy. None of the dogs had lesions or discomfort related to treatment; 3 out of 4 treated dogs did not have estrus until surgery (13-14 months of age) and 1 had estrus at 13 months; this dog had a corpus luteum and high progesterone concentrations. Ovaries were larger and had more follicles in treated dogs whereas endometrium was thicker in control. Commercially available antiGnRH can be a tool for reproductive management in prepubertal female dogs; however, further research is needed to confirm the long-term safety and duration of the contraceptive effect.

Zitieren

APA

Rocha, M., Favoreto, M., & Loureiro, B. (2026). Preliminary evaluation of a commercially available GnRH-based immunocontraceptive. Clinical Theriogenology, 18. https://doi.org/10.58292/ct.v18.13815

Vancouver

Rocha M, Favoreto M, Loureiro B. Preliminary evaluation of a commercially available GnRH-based immunocontraceptive. Clinical Theriogenology. 2026;18. doi:10.58292/ct.v18.13815

BibTeX
@article{Rocha2026,
  author = {Rocha, Milena and Favoreto, Mauricio and Loureiro, Barbara},
  title = {Preliminary evaluation of a commercially available GnRH-based immunocontraceptive},
  journal = {Clinical Theriogenology},
  year = {2026},
  volume = {18},
  doi = {10.58292/ct.v18.13815}
}
Kostenlos starten →